Patents by Inventor Thomas H. Sanderson

Thomas H. Sanderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220001197
    Abstract: A method and apparatus for minimizing tissue adhesion in a tissue of a subject includes applying light, to the tissue, that reduces at least one adhesion marker in the tissue, the light having wavelengths in at least one of a first wavelength range of 730-770 nm and a second wavelength range of 930-970 nm, wherein the at least one adhesion marker includes at least one of a transforming growth factor beta 1 (TGF-?1), a vascular endothelial growth factor, (VEGF), and a collagen alpha-1(I) chain (COL|?|), and wherein the light is free of wavelengths that increase the at least one adhesion marker.
    Type: Application
    Filed: October 31, 2019
    Publication date: January 6, 2022
    Inventors: Maik Huettemann, Mauri ce-Andre Recanati, Thomas H. Sanderson
  • Publication number: 20210252302
    Abstract: A method of treating reperfusion injury in a tissue of a subject in need thereof. The method includes applying light, to the tissue, that inhibits electron transfer from cytochrome c to cytochrome c oxidase (CcO) to molecular oxygen to attenuate creation of reactive oxygen species. The light includes wavelengths in a first wavelength range of 730-770 nm and a second wavelength range of 930-970 nm.
    Type: Application
    Filed: April 27, 2021
    Publication date: August 19, 2021
    Inventors: Maik Huettemann, John Kamholz, Icksoo Lee, Karin Przyklenk, Lawrence Grossman, Thomas H. Sanderson